Skip to content
lifestyle.briefmobile.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Mylan Inc.
U.S. FDA Accepts Viatris New Drug Application for Fast-Acting Meloxicam for the Treatment of Moderate-to-Severe Acute Pain
May 21, 2026
Viatris to Present at the Bank of America Securities 2026 Healthcare Conference
May 10, 2026
Viatris Reports First-Quarter 2026 Financial Results
May 10, 2026
Viatris Announces Quarterly Dividend
May 10, 2026
Viatris Announces Chief Financial Officer Transition
May 10, 2026
Viatris Announces Several Data Presentations on Investigational Low-Dose Estrogen Combined Hormonal Contraceptive Weekly Patch at the 2026 American College of Obstetricians and Gynecologists Annual Clinical & Scientific Meeting
May 9, 2026
Viatris to Report First Quarter 2026 Financial Results on May 7, 2026
May 7, 2026
Viatris Announces Multiple Data Presentations at the 2026 American Society of Cataract and Refractive Surgery Annual Meeting
May 6, 2026
Viatris to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026, and Host Investor Event on March 19, 2026
February 3, 2026
Viatris Appoints Matthew J. Maletta as Chief Legal Officer
February 3, 2026